STRS Ohio’s Arbutus Biopharma ABUS Stock Holding History

STRS Ohio’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$811K	Buy	+168,900	New	+$742K	﹤0.01%	838
2019 Q2	–	Sell	-10,300	Closed	-$36K	–	2106
2019 Q1	$36K	Hold	10,300	–	–	﹤0.01%	1922
2018 Q4	$39K	Hold	10,300	–	–	﹤0.01%	1911
2018 Q3	$97K	Hold	10,300	–	–	﹤0.01%	1838
2018 Q2	$75K	Buy	+10,300	New	+$61.3K	﹤0.01%	1910

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

STRS Ohio's ABUS Position: Q2 2026 in Review

STRS Ohio opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 168,900 shares worth $811K. The stake represents ﹤0.01% of the portfolio and ranks #838 among its holdings. This is a return to the name: STRS Ohio previously reported a position in ABUS as recently as Q1 2019.

STRS Ohio first reported a position in ABUS in Q2 2018 and has held it in 5 quarters since. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

STRS Ohio held 168,900 shares of Arbutus Biopharma worth $811K as of Q2 2026.
Arbutus Biopharma was a new STRS Ohio position in Q2 2026.
Arbutus Biopharma made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #838 holding.
STRS Ohio first reported a position in Arbutus Biopharma in Q2 2018 and has held it in 5 quarters since.
177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.